Helius Medical Announces Poster to Be Presented at the Consortium for Multiple Sclerosis Centers (CMSC) Annual Conference M2 Communications “ENP Newswire”
NEWTOWN, Pa. – Helius Medical Technologies, Inc. (Nasdaq: HSDT) (‘Helius’ or the ‘Company’), a neurotech company focused on neurological wellness, announced that an abstract highlighting real-world data, which shows the impact of translingual neurostimulation as a rehabilitation therapy to improve gait in people with multiple sclerosis (MS), has been selected for a poster presentation at the Consortium for Multiple Sclerosis Centers (CMSC) Annual Meeting taking place June 1-4 in National Harbor , Maryland .
‘We are excited to share our real-world findings on neuromodulation to improve MS patients’ ability to walk steadily and safely,’ said Antonella Favit-Van Pelt , MD, PhD, Helius Medical’s Chief Medical Officer. ‘Our findings show that neuromodulation stimulation is an effective rehabilitative intervention that is thought to engage mechanisms of upregulation and long-term potentiation, promoting neuroplasticity and improving gait functionality and mobility.’
